SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for CIRTRAN CORP (CIRX) (CIK 0000813716) (CIRX) — Nov 14, 2014

CIRTRAN CORP (CIRX) (CIK 0000813716)
Date: Nov. 14, 2014 · CIK: 0000813716 · Accession: 0000000000-14-057087

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-49654

Date
October 27, 2014
Author
/s/ Pamela Howell
Form
UPLOAD
Company
CIRTRAN CORP (CIRX) (CIK 0000813716)

Letter

November 14 , 2014 Iehab Hawatmeh Chief Executive Officer CirTran Corporation 4125 South 6000 West West Valley City, Utah 84128

Re: CirTran Corporation Form Schedule 14A Filed October 27, 2014 File No. 000-49654

Dear Mr. Hawatmeh :

We have limited our review of your filing to those issues we have addressed in our comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter within ten business days by amending your filing, by providing the requested information, or by advising us when you will provide the requested response. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your filing and the information you provide in response to these comments, we may have additional comments.

Proposal No. 1, page 5 1. We note that you have combined in Proposal No. 1 the reverse stock split and the reduction in the amount of common stock that is authorized. Rule 14a-4(a)(3) requires you to clearly identify each separate matter upon which you intend to act, whether or not related to or conditioned on the approval of other matters. Please revise to unbundle Proposal No. 1. If any of the proposals are mutually conditioned, please revise the proxy statement accordingly and provide appropriate disclosure regarding the effect of a negative vote on the related proposals.

2. We note on page 7 that the “formula for calculating the shares to be issued in connection with conversions of these securities varies, based on the market price of its common stock” and that there will be “no limitation on the number of shares of common stock that may be issued in connection with conversion” if the recapitalization plan is effected. We also note on page 8 that t here are “conversion limitations, or caps.” Please revise to provide further disclosure regarding the conversion feature of the note, including your

Iehab Hawatmeh CirTran Corporation November 14 , 2014 Page 2

estimation of the total number of shares that YA Global Investments, L.P. (“YA Global”) , will receive base d upon a range of market prices and the potential profit. Similarly, provide clear disclosure of the potential shares that may be issued upon exercise of the warrants and any other payments in stock related to this transaction. Discuss the dilutive effec t the issuance of common stock upon conversion will have upon investors and the downward pressure on stock market price.

3. Please provide tabular disclosure of payments (including the value of any payments to be made in common stock) in connection with the transaction that you have made or may be required to make to YA Global, or any affiliates , regarding the transaction (including any interest payments, liquidated damages, payments made to “finders” or “placement agents,” and any other payments or potential payments). Please provide footnote disclosure explaining each payment and any assumptions used in making these calculations. Please do not include any repayment of principal on the convertible notes in this disclosure.

4. Please provide us, with a view to ward disclosure in the proxy statement , with tabular disclosure of all prior securities transactions between the issuer (or any of its predecessors) and YA Global, any affiliates of YA Global, or any person with whom YA Global has a contractual relationshi p regarding the transaction (or any predecessors of those persons), with the table including the following information disclosed separately for each transaction: • the date of the transaction;

• the number of shares of the class of securities subje ct to the transaction that were outstanding prior to the transaction;

• the number of shares of the class of securities subject to the transaction that were outstanding prior to the transaction and held by persons other than YA Global, affiliates of the company, or affiliates of YA Global;

• the number of shares of the class of securities subject to the transaction that were issued or issuable in connection with the transaction;

• the percentage of total issued and outstanding securities that were iss ued or issuable in the transaction (assuming full issuance), with the percentage calculated by taking the number of shares issued and outstanding prior to the applicable transaction and held by persons other than YA Global, affiliates of the company, or affiliates of YA Global, and dividing that number by the number of shares issued or issuable in connection with the applicable transaction;

• the market price per share of the class of securities subject to the transaction immediately prior to the transact ion (reverse split adjusted, if necessary); and

Iehab Hawatmeh CirTran Corporation November 14 , 2014 Page 3

• the current market price per share of the class of securities subject to the transaction (reverse split adjusted, if necessary). 5. Please discuss in greater detail the current status of the convertible deb entures and the company’s ability to pay the obligations under the convertible debentures. General 6. Please revise to include a beneficial ownership table. See Item 6(d) of Schedule 14A and Item 403 of Regulation S -K. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable Exchange Act rules require. Since the compa ny and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.

In responding to our comments, please provide a written statement from the co mpany acknowledging that:

 the company is responsible for the adequacy and accuracy of the disclosure in the filing;

 staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

 the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please contact Hillary Daniels at (202) 551 -3959 or me at (202) 551-3357 with any other questions.

Sincerely,
/s/ Pamela Howell
for

Show Raw Text
November 14 , 2014

Iehab Hawatmeh
Chief Executive Officer
CirTran Corporation
4125 South 6000 West
West Valley City, Utah 84128

Re: CirTran Corporation
 Form Schedule 14A
Filed October 27, 2014
File No. 000-49654

Dear Mr. Hawatmeh :

We have limited our review of your filing to those issues we have addressed in our
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.

Please respond to this letter within ten business days by amending your filing, by
providing the requested information, or by advising us when you will provide the requested
response.   If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your filing and the information you provide in
response to these comments, we may have  additional comments.

Proposal No. 1, page 5
1. We note that you have combined in Proposal No. 1 the reverse stock split and the
reduction in the amount of common stock that is authorized.  Rule  14a-4(a)(3) requires
you to  clearly identify each separate matter upon which you intend to act, whether or not
related to or conditioned on the approval of other matters.  Please revise to unbundle
Proposal No. 1.  If any of the proposals are mutually conditioned, please revise the proxy
statement accordingly and provide appropriate disclosure regarding the effect of a
negative vote on the related proposals.

2. We note on page 7 that the “formula for calculating the shares to be issued in connection
with conversions of these securities  varies, based on the market price of its common
stock” and that there will be “no limitation on the number of shares of common stock that
may be issued in connection with conversion” if the recapitalization plan is effected.  We
also note on page 8 that t here are “conversion limitations, or caps.”  Please revise to
provide further disclosure regarding the conversion feature of the note, including your

Iehab Hawatmeh
 CirTran Corporation
 November 14 , 2014
 Page 2

 estimation of the total number of shares that YA Global Investments, L.P.  (“YA
Global”) , will receive base d upon a range of market prices and the potential profit.
Similarly, provide clear disclosure of the potential shares that may be issued upon
exercise of the warrants and any other payments in stock related to this transaction.
Discuss the dilutive effec t the issuance of common stock upon conversion will have upon
investors and the downward pressure on stock market price.

3. Please provide tabular disclosure of payments (including the value of any payments to be
made in common stock) in connection with the transaction that you have made or may be
required to make to YA Global, or any affiliates , regarding the transaction (including any
interest payments, liquidated damages, payments  made to “finders” or “placement
agents,” and any other payments or potential  payments).  Please provide footnote
disclosure explaining each payment and any assumptions used in making these
calculations.  Please do not include any repayment of principal on the convertible notes in
this disclosure.

4. Please provide us, with a view to ward disclosure in the proxy statement , with tabular
disclosure of all prior securities transactions between the issuer (or any of its
predecessors) and YA Global, any affiliates of YA Global, or any person with whom YA
Global has a contractual relationshi p regarding the transaction (or any predecessors of
those persons), with the table including the following information disclosed separately for
each transaction:
• the date of the transaction;

• the number of shares of the class of securities subje ct to the transaction that were
outstanding prior to the transaction;

• the number of shares of the class of securities subject to the transaction that were
outstanding prior to the transaction and held by persons other than YA Global,
affiliates of the company, or affiliates of YA Global;

• the number of shares of the class of securities subject to the transaction that were
issued or issuable in connection with the transaction;

• the percentage of total issued and outstanding securities that were iss ued or issuable
in the transaction (assuming full issuance), with the percentage calculated by
taking the number of shares issued and outstanding prior to the applicable
transaction and held by persons other than YA Global, affiliates of the company,
or affiliates of YA Global, and dividing that number by the number of shares
issued or issuable in connection with the  applicable transaction;

• the market price per share of the class of securities subject to the transaction
immediately prior to the transact ion (reverse split adjusted, if necessary); and

Iehab Hawatmeh
 CirTran Corporation
 November 14 , 2014
 Page 3

• the current market price per share of the class of securities subject to the transaction
(reverse split adjusted, if necessary).
5. Please discuss in greater detail the current status of the convertible deb entures and the
company’s ability to pay the obligations under the convertible debentures.
General
6. Please revise to include a beneficial ownership table.  See Item 6(d) of Schedule 14A and
Item 403 of Regulation S -K.
We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the information the Securities Exchange Act of
1934 and all applicable Exchange Act rules require.   Since the compa ny and its management are
in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.

 In responding to our comments, please provide  a written statement from the co mpany
acknowledging that:

 the company is responsible for the adequacy and accuracy of the disclosure in the filing;

 staff comments or changes to disclosure in response to staff comments do not foreclose
the Commission from taking any action with respect to the filing; and

 the company may not assert staff comments as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.

Please contact Hillary Daniels  at (202) 551 -3959  or me at (202) 551-3357  with any other
questions.

Sincerely,

 /s/ Pamela Howell
 for

 John Reynolds
Assistant Director

cc: James R. Kruse, Esq.
 Kruse Landa Maycock & Ricks, LLC